Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older).

Novartis Pharmaceuticals · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
fascioliasis, acute fascioliasis, chronic fascioliasis, clinical cure, parasitological cure, egaten, triclabendazole, post-marketing commitment, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1045774
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.